Steven Bauer

Dr. Steven Bauer

orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Cell Stem Cell
Verified
Journal Article
Closed access
MMMichael Mendicino
Michael Mendicino
ABAlexander M. Bailey
Alexander M. Bailey
KWKeith Wonnacott
Keith Wonnacott
RPRaj K. Puri
Raj K. Puri
SBSteven Bauer
Steven Bauer

20 July 2011 in Nature
Verified
Journal Article
Open access
PDF file
SFSacri R. Ferrón
Sacri R. Ferrón
MCMarika Charalambous
Marika Charalambous
ERElizabeth Radford
Elizabeth Radford
KMKirsten McEwen
Kirsten McEwen
HWHendrik Wildner
Hendrik Wildner
AFAnne Ferguson-Smith
Anne Ferguson-Smith
Life-long neurogenesis is known to occur in some areas of the mammalian adult brain, including in the subventricular zone (SVZ), where interaction between neural precursor cells and resident astrocytes can produced migratory neuroblasts. Here, Anne Ferguson-Smith and colleagues reveal a differential role for the same developmental gene, Dlk1, in neural precursor cells and astrocytes. The gene product, the Notch ligand DLK1, has two isoforms. One is an inductive niche factor secreted by astrocytes, and the other is a membrane-bound isoform required by the neural stem cells themselves to respond to secreted DLK1. Selective changes of imprinting with age modulate the role of Dlk1 in each cell type in mice, regulating neurogenesis when establishing the adult neurogenic niche. The modulation of genomic imprinting in a stem-cell environment adds a previously unrecognized element to epigenetic regulation. The gene for the atypical NOTCH ligand delta-like homologue 1 (Dlk1) encodes membrane-bound and secreted isoforms that function in several developmental processes in vitro and in vivo. Dlk1, a member of a cluster of imprinted genes, is expressed from the paternally inherited chromosome1,2. Here we show that mice that are deficient in Dlk1 have defects in postnatal neurogenesis in the subventricular zone: a developmental continuum that results in depletion of mature neurons in the olfactory bulb. We show that DLK1 is secreted by niche astrocytes, whereas its membrane-bound isoform is present in neural stem cells (NSCs) and is required for the inductive effect of secreted DLK1 on self-renewal. Notably, we find that there is a requirement for Dlk1 to be expressed from both maternally and paternally inherited chromosomes. Selective absence of Dlk1 imprinting in both NSCs and niche astrocytes is associated with postnatal acquisition of DNA methylation at the germ-line-derived imprinting control region. The results emphasize molecular relationships between NSCs and the niche astrocyte cells of the microenvironment, identifying a signalling system encoded by a single gene that functions coordinately in both cell types. The modulation of genomic imprinting in a stem-cell environment adds a new level of epigenetic regulation to the establishment and maintenance of the niche, raising wider questions about the adaptability, function and evolution of imprinting in specific developmental contexts.

1 February 1993 in Immunology Today
Verified
Journal Article
Closed access
FMFritz Melchers
Fritz Melchers
HKHajime Karasuyama
Hajime Karasuyama
DHDirk Haasner
Dirk Haasner
SBSteven Bauer
Steven Bauer
AKAkira Kudo
Akira Kudo
ARAntonius Rolink
Antonius Rolink

10 March 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MKMatthew W. Klinker
Matthew W. Klinker
RMRoss A. Marklein
Ross A. Marklein
JSJessica L. Lo Surdo
Jessica L. Lo Surdo
CWCheng-Hong Wei
Cheng-Hong Wei
SBSteven Bauer
Steven Bauer
Significance: Substantial evidence exists demonstrating the immunosuppressive function of mesenchymal stromal cells (MSCs), but inconsistent clinical results suggest that better understanding of MSC-mediated immunosuppression and identification of features predictive of immunosuppressive capacity would advance MSC-based therapeutics. In this work, we present a robust analytical approach to quantify the immunosuppressive capacity of MSCs by integrating high-dimensional flow cytometry data from multiple experimental conditions into a single measure of immunosuppressive capacity. Additionally, we identified morphological features of MSCs that predicted immunosuppressive capacity, as well as the magnitude of IFN-γ–mediated immunosuppression enhancement. These improved methods of MSC characterization could be used to identify MSC preparations with desired immunosuppressive capacity, as well as screen for pretreatments that enhance their immunosuppressive function.

1 March 2008 in Medicine
Verified
Journal Article
Closed access
ABApril Bingham
April Bingham
GMGulnara Mamyrova
Gulnara Mamyrova
KRKristina I. Rother
Kristina I. Rother
EOElif Oral
Elif Oral
ECElaine Cochran
Elaine Cochran
LRLisa Rider
Lisa Rider
Fat loss distribution. LD onset was often delayed, beginning a median of 4.6 years after diagnosis of DM. Calcinosis, muscle atrophy, joint contractures, and facial rash were DM disease features found to be associated with LD. Panniculitis was associated with focal lipoatrophy while the anti-p155 autoantibody, a newly described myositis-associated autoantibody, was more associated with generalized LD. Specific LD features such as acanthosis nigricans, hirsutism, fat redistribution, and steatosis/nonalcoholic steatohepatitis were frequent in patients with LD, in a gradient of frequency and severity among the 3 sub-phenotypes. Metabolic studies frequently revealed insulin resistance and hypertriglyceridemia in patients with generalized and partial LD. Regional fat loss from the thighs, with relative sparing of fat loss from the medial thighs, was more frequent in generalized than in partial LD and absent from DM patients without LD. Cytokine polymorphisms, the C3 nephritic factor, insulin receptor antibodies, and lamin mutations did not appear to play a pathogenic role in the development of LD in our patients. LD is an under-recognized sequela of JDM, and certain DM patients with a severe, prolonged clinical course and a high frequency of calcinosis appear to be at greater risk for the development of this complication. High-risk JDM patients should be screened for metabolic abnormalities, which are common in generalized and partial LD and result in much of the LD-associated morbidity. Further study is warranted to investigate the pathogenesis of acquired LD in patients with DM. Abbreviations: CI = confidence interval, CT = computerized tomography, dlk = delta-like, DM= dermatomyositis, DXA = dual-energy X-ray absorptiometry, HDL = high-density lipoprotein, HIV = human immunodeficiency virus, HOMA-IR = homeostasis model assessment of insulin resistance, IL = interleukin, IR = insulin resistance, JDM = juvenile dermatomyositis, LA = lipoatrophy, LD = lipodystrophy, LDL = low-density lipoprotein, LMNA= lamin A, MRI = magnetic resonance imaging, NASH = nonalcoholic steatohepatitis, NIH = National Institutes of Health, OGTT = oral glucose tolerance test, OR = odds ratio, PCR = polymerase chain reaction, TNF = tumor necrosis factor, TTP = tristetraprolin....

20 May 1983 in Science
Verified
Journal Article
Closed access
PDF file
JMJ. Frederic Mushinski
J. Frederic Mushinski
MPMichael Potter
Michael Potter
SBSteven Bauer
Steven Bauer
ERE. Premkumar Reddy
E. Premkumar Reddy
SBS R Bauer
S R Bauer
Three types of tumors termed plasmacytomas (ABPC's), lymphosarcomas (ABLS's), and plasmacytoid lymphosarcomas (ABPL's) arise in BALB/c mice treated with pristane and Abelson murine leukemia virus (A-MuLV). While most ABPC's and ABLS's contain integrated A-MuLV proviral genome and synthesize the v- abl RNA, most ABPL's do not. The ABPL tumors were examined for the expression of other oncogenes that may be associated with their transformed state, in the absence of transforming virus. These tumors expressed abundant c- myb RNA of unusually large size and showed DNA rearrangements of the c- myb locus.